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The dog is a common model for study of osteoarthritis (OA). Subjective histologic scoring systems have
often served as the reference standard for presence and severity of OA. However, these scoring systems
have perceived shortcomings. The system developed for this report attempts to address these short-
comings by providing a standardized methodology for global assessment of the joint, versatility and the
potential for relative weighting of pathology, allowing for comparison among time points, studies, and
centers, and critical analysis of the system’s reliability. The proposed system for assessment of canine
tissues appears to provide an effective method for global assessment of articular pathology in OA. The
system is versatile, comprehensive, and reliable and appears to have advantages over conventional
scoring systems.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Histologic assessment of osteoarthritis (OA) is currently
considered the gold standard for determining presence, extent and
severity of OA. The dog is the most studied species with respect to
models of OA (see Table I for an overview) and, importantly,
spontaneously occurring OA is common in dogs in multiple joints
from various etiologies. The vast majority of laboratory and clinical
studies have used the Mankin or modiﬁed Mankin scoring systems
to determine the presence or absence of OA and assess the extent
and severity of OA based on subjective identiﬁcation of histologic
criteria of articular cartilage pathology (Table II). While this
methodology has produced a vast amount of useful and relatively
repeatable data, a comprehensive literature search (PubMed and
Medline,1e74) in conjunction with review by recognized experts in
the ﬁeld (authors) suggest that important limitations exist
including:James L. Cook, University of
ast Campus Drive, Columbia,
-2683.
s Research Society International. P, This methodology only assesses articular cartilage pathology
and does not consider other tissues including synovium, sub-
chondral bone, or menisci, which are known to be important
components of initiation and progression of OA (i.e., the joint is
an organ comprised of multiple cell and tissue types).
, This methodology does not provide a global assessment of the
joint, only those areas evaluated histologically.
, The scoring systems arbitrarily assign values to different
degrees of pathology and overall values to various categories
evaluated (e.g., structural changes, changes in matrix compo-
sition, and cellular changes) without making attempts to
“weight” the scores for each category based on relative impor-
tance in OA.
, There is no standardized methodology for number of sections
scored, location of sections for scoring, or ensuring normaliza-
tion of staining for comparison between batches, studies, or
institutions.
, This methodology has not been extensively analyzed for
statistical validity nor has it been truly validated to clinical or
functional outcome measures.
Therefore, the purpose of this work is to attempt to address the
majority of these limitations by developing, and then subsequently
validating, a comprehensive histologic assessment system that isublished by Elsevier Ltd. All rights reserved.
Table I
Table listing the most important models available in dog for studying joint
degeneration
Type of models Published models References
Spontaneous OA-models Canine Hip Dysplasia 35 (and >200 others)
Canine Elbow Dysplasia 69 (and >100 others)
Anterior Cruciate
Deﬁciency
28 (and >100 others)
Surgically induced
OA models
Anterior Cruciate
Transection
55 (and >400 others)
Meniscectomy 5,13,27,32,33,70
and others
Abrasion 1,3
Groove 39e42
ALD/Valgus Osteotomy 29,49,50
Cartilage Defects 6,7,9,67, and others
Reverse Triple Pelvic
Osteotomy
26
Enzymatic/Chemically
induced OA
Iodoacetate 5
Papain and Prednisone 61
Papain/Chymopapain 11
Calcium Pyrophosphate
Crystals
43,44,56
Oral Quinolones 10
Impact models Acute patellofemoral
loading
54,63,65
Genetically induced Models
e Transgenic animals
None for dogs
Table II
Table listing previously proposed grading and staging systems for canine cartilage
degeneration
References Comment
Grading systems 36 Cartilage grading system
(Mankin grade)
10,30,60,68 Cartilage grading system
(modiﬁed Mankin grade)
12 For treatment of cartilage defects, rather
than for OA grading
23,45,53 Synovium grading system
17 Meniscus
Staging systems 48 Primarily developed for humans
24 Primarily developed for humans
42 Macroscopic score based on
high-resolution photographs
Fig. 1. Comparative radiographic (A) and gross (B, C) anatomy of the canine stiﬂe (top row) a
the gross images show normal patellofemoral joints (B) and normal tibial plateaus (C). The c
large breed dogs (upper left panel A) compared to approximately 7e10 cm for the human
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institutions. For the purpose of this work, we use the term
“grading” for microscopic/macroscopic scoring of tissues and the
term “staging” for the overall assessment of the disease status.Anatomy and joint pathology of the dog knee joint
The focus of the majority of previous research, and of the
present work, is the knee (stiﬂe) joint of the dog. However, other
joints have also been extensively studied in the dog and have
importance especially for spontaneously occurring disease, partic-
ularly dysplasias which cause secondary OA in the hip and elbow.
However, the present work will focus only on the knee as this joint
is the most frequently used as a model of OA.
The anatomy of the canine knee is closely matched to that of
the human (Fig. 1). Both macroscopic and microscopic anatomies
are very similar apart from size. The canine knee has medial and
lateral femorotibial compartments and a patellofemoral
compartment as does man. The anterior (cranial) and posterior
(caudal) cruciate ligaments, menisci, meniscal ligaments, fat pad,
and patellar ligaments match the human in form and function
very closely. The only major gross anatomical differences are that
the dog has an intra-articular long digital extensor tendon, which
crosses the joint in the anteriorelateral compartment, and that
the dog has lateral and medial fabella (sesamoids) in the heads of
the gastrocnemius muscle, as well as a popliteal sesamoid.
Biomechanically, there are differences with respect to amount of
load transmission, relative joint congruency and laxity, range of
motion, weight bearing angle, tibial slope, and tibial thrust.
Histologically and biochemically, articular cartilage, subchondral
bone, synovium, joint capsule, and menisci are very well
conserved between these two species. Importantly, spontaneously
occurring pathology in terms of anterior cruciate ligament deﬁ-
ciency, meniscal pathology, osteochondrosis, and trauma is
comparable in all facets between man and dog. This is one major
advantage when using dogs for translational research in OA
compared to smaller species where macro and microscopic
anatomy, cartilage composition, and matrix turnover may signif-
icantly differ from that of humans.nd human knee (bottom row). The radiographic images show osteoarthritic joints while
anine stiﬂe joint is approximately 3.5e5 cm from medial to lateral edge for medium to
knee joint (lower left panel A).
Table III
Macroscopic scoring of cartilage
Smooth surface e Outerbridge 0 0
Slightly ﬁbrillated/roughened surface e Outerbridge 1 1
Fibrillated surface with focal partial thickness lesions e Outerbridge 2 2
Deep lesions with surrounding damage e Outerbridge 3 3
Large areas of severe damage e Outerbridge 4 4
Macroscopic cartilage scoring for each compartment, based on original Outerbridge
classiﬁcation (Outerbridge, 1961), and modiﬁed from Mastbergen et al Rheuma-
tology 2006.
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status, and breed, which may signiﬁcantly inﬂuence joint physi-
ology and even more so affect outcomes after experimentally
induced OA. To the authors’ knowledge, none of these variables
have been studied to a degree that allows deﬁnitive recommen-
dations to be made with respect to choice or management of
research animals. However, it is recommended to use animals that
have no clinical or radiographic signs of spontaneous joint
pathology in any weight bearing joint. It is also advisable to use
dogs that are skeletally mature (9e18 months old depending on
breed and gender), as deﬁned by radiographically closed growth
plates. If possible, use of non-chondrodystrophic breeds (i.e., not
Beagles, Dachshunds, etc. which are chondrodystrophic by deﬁni-
tion) may be optimal for avoiding any potential confounding vari-
ables associated with chondrodystrophy. Use of a batch of dogs that
are genetically closely related, of the same gender, and within
narrow age and weight ranges may limit variability in outcome
measures. However, use of dogs of both genders that are genetically
diverse may provide a more valid representation of spontaneously
occurring OA for translation to the human patient population.
Pre-study power analyses are always recommended; based on
presently available data in the literature, a minimum of eight
animals per group is suggested.Scoring of Alterations in Joint structures
Macroscopic scoring of cartilage alterations
Macroscopic scoring is critical to include, in order to provide
some measure or indication of global joint pathology. Ideally, this
should be objective and quantitative. However, experimental
design may inﬂuence the investigators’ ability to include quanti-
tative methodology for this aspect of assessment of OA.
(A) When parallel or subsequent outcome assessments do not
require aseptic technique, a quantitative macroscopic scoring
system using India ink staining and calculation of surface area
affected is recommended (See Appendix B).
(B) When parallel or subsequent assessments require aseptic
technique (i.e., explant or cell culture), the following macro-
scopic scoring system is suggested. A score is assigned to each
of four major weight bearing surfaces: medial femoral condyle,
lateral femoral condyle, medial tibial plateau, lateral tibial
plateau. The score is assigned based on the criteria in Table III
and is determined by the most severe pathology noted (Fig. 2).
When gross macroscopic scoring is used, blinding of scorers is
a prerequisite and thereforehigh-resolutionphotographsneed to be
taken for subsequent scoring by multiple independent observers.Microscopic scoring of cartilage alterations
(A) When osteochondral sections of the entire surface of each
major joint area are desired for histologic assessment,
a minimum of three sections of tissue should be evaluated for
each of the compartments/regions listed below. The sections
should be cut to be approximately 1e3 mm apart and span the
entire surface of interest. We recommend taking sagittal
osteochondral sectionswhich span the entire surface of interest
for all four compartments: Lateral femoral condyle, Medial
femoral condyle, Lateral tibial plateau, andMedial tibial plateau
(see Appendix A describing methods for cartilage sectioning,
Approach A). Depending on study purpose and hypothesis,
evaluation of patella and trochlear groove may be important.(B) When histologic assessment is focused on articular cartilage
and/or portions of cartilage or bone are to be used for speciﬁc
purposes that prohibit approach A (e.g., explant or cell culture,
micro-CTof subchondral bone sections), then at least 4 samples
of cartilage from ﬁxed pre-deﬁned locations of the weight
bearing areas of all four compartments listed above should be
sampled and compared to control samples from the same
locations in the control knees (see Appendix A describing
methods for cartilage sectioning, Approach B).
For both approaches, the following protocol should be
employed:
, Minimum of two blinded reviewers, independent evaluations.
, First two below are mandatory, and also recommend including
collagen stain and/or polarized light microscopy for all:
B Hematoxylin and eosin e general architecture and cell
features.
B Toluidine blue or Safranin O fast green e proteoglycan.
B Picrosirius red (polarized) e collagen.
For proteoglycan and picrosirius red staining, it is a prerequisite
to stain controls and experimental sections in the same batch or to
use an internal control that is stained as a reference in every batch.
As mentioned, current histologic grading systems use multiple
categories to derive a total score for cartilage pathology. Often, only
one or two sections are used and only a focal area of the section(s) is
assessed. This methodology does not provide a comprehensive
assessment of joint pathology. In addition, these grading systems
arbitrarily assign values to different degrees of pathology and to
a given category without making attempts to “weight” the scores
for each category based on relative importance in cartilage
pathology. By grading cartilage (and bone) structure using multiple
sections which span the entire surface for each major joint
compartment and then separately grading the other major cate-
gories of cartilage pathology, the stated problems with current
cartilage grading are minimized. Cartilage (and bone) structure is
suggested as the primary outcome measure as it (1) provides
a method for histologically assessing global changes in cartilage
integrity as can be done in parallel using gross, arthroscopic, and
imaging measures so that subsequent correlations among these
assessments of joint health and disease status can be analyzed, (2)
allows investigators to consider the entire section of interest and
not try to determine an overall score from a focal change, and (3)
provides a standardized methodology that can be validated for use
across studies, institutions, models, and species.
The Tables IVeIXprovide grading systems for eachmajor category
of cartilage and subchondral bone pathology. It may be relevant to
choose one or more of these categories, depending on model and
study design in order to gain insight intomechanisms of disease and/
or speciﬁc treatment effects. It is then possible to make comparisons
and test for correlationsamongcategories. Certainly, it is alsopossible
to combine someorall scores for a global score aswell, but indoingso
Fig. 3. Representative safranin O fast green-stained photomicrographs providing examples for microscopic grading of cartilage, chondrocyte, and proteoglycan pathology using
Tables IVeVI. The panels AeE for each of the three characteristics represent the descriptions AeE for each of these three characteristics as described in Tables IVeVI indicated by
arrows or arches in these ﬁgures. The lower row of ﬁgures depicts cartilage-bone samples with the bone-cartilage interface visible for use when samples are obtained according to
histologic sectioning method A (see Appendix A). In this case, integrity of the tidemark and subchondral bone changes can be graded as well according to Tables VIII and IX. (B) and
(C) in this ﬁgure refer to Table VIII.
Fig. 2. Images showing examples of each category for macroscopic scoring of femoral condyles and tibial plateaus from high-resolution photographs. From left to right starting from
a completely smooth surface (panel A) there is increase in ﬁbrillation/roughening of the articular surface of both the weight bearing areas of the femoral condyles and the tibial
plateau (see arrows in panels B and C). Subsequently focal partial thickness lesions become visible (arrows in panel C), leading to deeper lesions with surrounding damage as seen in
panel D (arrows). Finally large areas of severe damage can be observed (panel E).
J.L. Cook et al. / Osteoarthritis and Cartilage 18 (2010) S66eS79 S69
Table IV
Grading of cartilage structure (see Fig. 3a for examples)
Severity of cartilage pathology
Characteristics
Area of section affected
None Local (approx 1/3) Multi-focal (approx 2/3) Global (>2/3)
A Normal volume, smooth surface with all zones intact 0 0 0 0
B Surface undulations including ﬁssures in surface/upper zone
and/or pannus tissue formation on surface
0 1 2 3
C Fissures to mid zone and/or erosion of surface/upper zone 0 2 4 6
D Fissures that extend to deep zone and/or erosion through mid zone 0 3 6 9
E Full thickness loss of cartilage 0 4 8 12
Table V
Grading of chondrocyte pathology (See Fig. 3a for examples)
Severity of chondrocyte pathology
Characteristics
Area of section affected
None Local (approx 1/3) Multi-focal (approx 2/3) Global (>2/3)
A Normal 0 0 0 0
B Loss of cells in the surface zone or relative increased density
with occasional superﬁcial clusters
0 1 2 3
C Small cell clusters (2e4 cells/cluster)* predominate 0 2 4 6
D Large cell clusters (5 cells/cluster) predominate 0 3 6 9
E Cell loss (necrosis/apoptosis) predominates 0 4 8 12
* In any cartilage zone.
Table VI
Grading of proteoglycan staining (see Fig. 3a for examples)
Severity of proteoglycan pathology
Characteristics
Area of section affected
None Local (approx 1/3) Multi-focal (approx 2/3) Global (>2/3)
A Normal 0 0 0 0
B Decreased proteoglycan content in surface/upper zone 0 1 2 3
C Decreased proteoglycan content into the mid zone 0 2 4 6
D Decreased proteoglycan content into the deep zone 0 3 6 9
E Full depth decrease in proteoglycan content 0 4 8 12
Table VII
Grading of collagen integrity
Severity of collagen pathology
Characteristics
(Based on intensity of picrosirius red staining and/or polarized light evaluation)
Area of section affected
None Local (approx 1/3) Multi-focal (approx 2/3) Global (>2/3)
A Normal 0 0 0 0
B Loss of integrity of surface/upper zone 0 1 2 3
C Loss of integrity of surface/upper and mid zones 0 2 4 6
D Loss of integrity of surface/upper, mid, and deep zones 0 3 6 9
Table VIII
Grading of tidemark (If using full thickness osteochondral sections e recommended) (Fig. 3b)
Tidemark integrity Area of section affected
None Local (approx 1/3) Multi-focal (approx 2/3) Global (>2/3)
A Intact and distinct 0 0 0 0
B Not consistent or distinct (loss and/or duplication) 0 1 2 3
C Loss of tidemark which is crossed by blood vessels 0 2 4 6
Table IX
Grading of subchondral bone plate (If using full thickness osteochondral sections e recommended)
Subchondral bone plate change Area of section affected
None Local (approx 1/3) Multi-focal (approx 2/3) Global (>2/3)
A Intact with normal thickness (300 microns) 0 0 0 0
B Mild increase in thickness (>300e<450 mm) 0 1 2 3
C Moderate increase in thickness (450e<750 mm) 0 2 4 6
D Marked increase in thickness (>750 mm),
subchondral pseudocysts, and/or marrow ﬁbrosis
0 3 6 9
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Table X
Macroscopic scoring of synovial pathology
Gross Characteristics Score
Normal e opal white, semitranslucent, smooth, with sparse well deﬁned blood vessels 0
Slight e focal involvement, slight discoloration, visible proliferation/ﬁmbriation/thickening, notable increase in vascularity 1
Mild e diffuse involvement, slight discoloration, visible proliferation/ﬁmbriation/thickening, notable increase in vascularity 2
Moderate e diffuse involvement, severe discoloration, consistent notable proliferation/ﬁmbriation/thickening, moderate vascularity 3
Marked e diffuse involvement, severe discoloration, consistent and marked proliferation/ﬁmbriation/thickening, diffuse hypervascularity 4
Severe e diffuse involvement, severe discoloration, consistent and severe proliferation/ﬁmbriation/thickening, thickening
to the point of ﬁbrosis, and severe hypervascularity
5
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pathology by category score, which may be inappropriate.
This grading system is designed to be comprehensive and
speciﬁc. As described above, multiple sections should be evalu-
ated and the entirety of the section should be evaluated for each
category (table) used. When a section includes several local areas
of pathology or local and multi-focal pathology, then the scores
are added to derive a total score for the section. The score is
based on the most severe pathology seen in each area of the
section you are evaluating based on the descriptors provided in
each table.
Examples:
1/3 of section scored Bþ 1/3 scored Cþ 1/3 scored D¼ 1þ2þ 3¼ 6
1/3 of section scored Bþ 2/3 scored D¼ 1þ6¼ 7
2/3 of section scored Bþ 1/3 scored C¼ 2þ 2¼ 4
1/3 of section scored Eþ rest of section normal¼ 4þ 0¼ 4
Entire section scored B¼ 3¼ 3
Macroscopic scoring of synovial alterations
An overall view on the synovial tissue as large as possible, at
least including the tissue below the patella and the medial and
lateral sides of the joint capsule from patellar ligament to lateralFig. 4. Gross (A) and arthroscopic (B) images showing examples ofand medial attachments should be scored by a minimum of two,
blinded observers based on the scoring system in Table X (Fig. 4).
Microscopic scoring of synovial alterations (Grading of
synoviopathy)
Aminimum of three sections of tissue should be evaluated from
medial, axial, and lateral compartments of each joint. The sections
should be representative of the entire tissue (Table XI, Fig. 5).
, Minimum of two blinded reviewers, independent evaluations.
, Use H&E stain.
Microscopic scoring and micro-CT analysis of bone alterations
Table IX provides themechanism for assessing subchondral bone
when included for evaluation. Bone morphometry can be per-
formed when histologic sectioning method A (see Appendix A) is
chosen as has been described.When histologic sectioningmethod B
(Appendix A) is chosen, micro-CT analyses of bone architecture can
be performed. Three-dimensional subchondral plate thickness,
trabecular bone volume fraction, three-dimensional trabecular
thickness, structure model index, and connectivity density can be
calculated and expressed in objective, quantitative measures foreach score (0e5) for synovial pathology according to Table X.
Table XI
Microscopic grading of synovial changes
Severity of pathology Area of section affected
Lining cells characteristics None Local (approx 1/3) Multi-focal (approx 2/3) Global (>2/3)
A 1e2 layers of cells 0 0 0 0
B 3e6 layers of cells 0 1 2 3
C >6 layers of cells 0 2 4 6
Lining characteristics
A No villous hyperplasia 0 0 0 0
B Short villi 0 1 2 3
C Finger-like hyperplasia 0 2 4 6
Cell inﬁltration characteristics
A No cellular inﬁltration 0 0 0 0
B Mild to moderate inﬂammatory cell inﬁltrates including small lymphoid follicles 0 1 2 3
C Marked, diffuse inﬂammatory cell inﬁltrates including large lymphoid follicles 0 2 4 6
Fig. 5. Representative hematoxylin and eosin-stained photomicrographs providing examples for microscopic grading of synovial pathology using Table XI. The panels A-C for each
of the three characteristics represent the descriptions AeC for each of these three characteristics as described in Table XI indicated by arrows or arches in these ﬁgures.
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Table XII
Macroscopic scoring of meniscal changes
Severity of meniscal pathology characteristics Area of section affected
Anterior 1/3 Middle 1/3 Posterior 1/3
A None 0 0 0
B Fibrillation only 1 1 1
C Incomplete tear or tears 2 2 2
D Complete tear or tears 3 3 3
E Complete disruption of structure (maceration of tissue) 4 4 4
Table XIII
Microscopic grading of meniscal changes
Category Score
Tissue Architecture-Tissue Loss Anterior 1/3 Middle 1/3 Posterior 1/3
Normal 0 0 0
Minimal disruption 1 1 1
Moderate disruption with loss of tissue 2 2 2
Complete loss of tissue architecture, >50% loss 3 3 3
Total Tissue Architecture-Tissue Loss Score
Cell and Matrix (PG and Collagen) Content and Morphology Anterior 1/3 Middle 1/3 Posterior 1/3
Normal 0 0 0
Minimal alterations in cell and matrix content and morphology 1 1 1
Moderate alterations in cell and matrix content and morphology 2 2 2
Severe loss/disruption of cells, PG, and collagen 3 3 3
Total Cell and Matrix Score
Proliferative Response Anterior 1/3 Middle 1/3 Posterior 1/3
None 0 0 0
Minimal proliferation of cells at synovial-meniscal junction 1 1 1
Proliferation of cells at synovial junction and extending into tissue or along surfaces 2 2 2
Marked proliferation of cells involving majority of remaining tissue 3 3 3
Total Proliferative Response Score
TOTAL SCORE
Fig. 6. e Photomicrographs of menisci showing (A) normal safranin O fast green-stained meniscus at low magniﬁcation, (B) safranin O fast green-stained meniscus at low
magniﬁcation showing grade three changes in all three categories, (C) safranin O fast green-stained meniscus at high magniﬁcation showing grade three tissue architecture-tissue
loss change, (D) safranin O fast green-stained meniscus at high magniﬁcation showing grade three cell and matrix change, (E) safranin O fast green-stained meniscus at high
magniﬁcation showing grade three proliferative response change.
J.L. Cook et al. / Osteoarthritis and Cartilage 18 (2010) S66eS79 S73
J.L. Cook et al. / Osteoarthritis and Cartilage 18 (2010) S66eS79S74each of the four joint compartments as well as for areas in the
metaphysis as a control. These parameters have been demonstrated
to change with development of OA in humans as well as dogs and
other animal models of OA72e74. Both methods allow for incorpo-
ration of subchondral bone changes in a “whole organ” approach to
assessment of OA, as well as correlation of these data to other
clinically relevant outcome measures such as MRI. The authors
strongly recommend this whole organ approachwhen using canine
models of OA for comparative and translational research.
Microscopic scoring of meniscal alterations
Meniscal scoring and grading systems:
Macroscopic. Meniscal pathology is scored for each zone (ante-
rior (cranial), middle, and posterior (caudal) thirds) of each
meniscus (medial and lateral) according to the criteria outlined
in Table XII:
Scores from all sections are added to derive a total severity score
for each meniscus with a maximum score of 12. Individual scores
for each section can also be used depending on study purpose and
hypothesis.
Microscopic. Medial and lateral menisci are each divided into
anterior (cranial), middle, and posterior (caudal) thirds: three
sections from each third are used for evaluation (Table XIII, Fig. 6).
The following protocol should be employed:
, Minimum of two blinded reviewers, independent evaluations.
, Mandatory two stains, recommend including collagen stain and
or polarized light microscopy for all:
B Hematoxylin and eosin e general architecture and cell
features.
B Toluidine blue or Safranin O fast green e proteoglycan.
B Picrosirius red and/or polarized e collagen.
Scores from all sections are added to derive a total score for each
category for each meniscus. A total score for each meniscus can
then be derived by adding all category scores. Individual scores for
each section can also be used depending on study purpose and
hypothesis.
Evaluation of sources of variability
In order to validate the reliability of this histologic assessment
system, we enlisted experts (six individuals with training and
experience in histologic assessment of articular tissues) and non-
experts (four individuals with training and experience in histo-
logic assessment, but not of articular tissues) to review images
and use the system to score each image after reading the
instructions for scoring. Images were divided into three cate-
gories: (1) Cartilage (n¼ 28 images using Tables IVeVI), (2)
Osteochondral (n¼ 17 images using Tables IVeVI, VIII and IX),
and (3) Synovium (n¼ 31 images using Table XI). A total score
was determined for each reviewer in each category. Scores were
analyzed in each category using Repeated Measures ANOVA on
Ranks to determine signiﬁcant differences in scores among
observers, Spearman Rank Order Correlation test to assess the
strength of correlations among observers, and a weighted Kappa
test to assess inter-observer agreement. For the correlations, we
considered r> 0.4 to moderately strong and r> 0.7 to be strong.
For the weighted kappa test, we considered k> 0.2 to be fair
agreement, k> 0.4 to be moderate agreement, k> 0.6 to be good
agreement, and k> 0.8 to be very good agreement (Altman DG
(1991) Practical statistics for medical research. London: Chapman
and Hall).Each statistical analysis method indicated that the scoring
systems were reliable when performed by experts. No signiﬁcant
differences in scores were noted among experts in any category.
However, some signiﬁcant (p< 0.001) differences in scores were
noted between experts and non-experts and among non-experts,
most notably in the Osteochondral category. Correlation analyses
revealed that Cartilage category scoring was very similar among
all observers with all observer comparisons having signiﬁcant
(p< 0.001) moderate to strong (r¼ 0.56e0.95) positive correla-
tions. For Osteochondral category scoring, all experts had
signiﬁcant (p< 0.001) strong (r¼ 0.79e0.96) positive correla-
tions, while only weak correlations (r< 0.4) were seen for expert
to non-expert and non-expert to non-expert comparisons. For
Synovium category scoring, all observers scores had signiﬁcant
(p< 0.001) strong (r¼ 0.7e0.92) positive correlations. Similar
ﬁndings were seen for weighted Kappa analyses. For Cartilage
category scoring, inter-observer agreement ranged from fair
(k¼ 0.48) for non-expert to non-expert comparison to very good
(k¼ 0.87) for expert to expert comparison. For Osteochondral
category scoring, inter-observer agreement ranged from slight
(k¼ 0.27) for non-expert to non-expert comparison to good
(k¼ 0.68) for expert to expert comparison. For Synovium cate-
gory scoring, inter-observer agreement was in the good range
(k¼ 0.64e0.80) for all comparisons. Taken together, these data
suggest this histologic assessment system is reliable in terms of
producing consistent and repeatable scores for cartilage, osteo-
chondral, and synovial tissue status among observers with
expertise and experience in articular tissue histology. The data
also suggest that non-experienced observers using the system for
the ﬁrst time can effectively assess tissues to acceptable levels of
agreement with experts.
Discussion
The dog is a commonly used and appropriate model for
translational and comparative study of all aspects of OA based on
animal size; anatomical, disease mechanism, and clinical simi-
larities to humans; and response to treatments. In addition, OA
occurs in dogs in very similar ways to that seen in humans as
a result of traumatic, degenerative, and overuse etiologies.
Historically, histologic evaluation of articular cartilage pathology
associated with OA has been used as the “gold standard” for
determining the presence, extent, and severity of disease in all
species. Subjective scoring systems have served to provide
a mechanism for histologic degree of OA among subjects, treat-
ment groups, studies, and with respect to historical data sets.
However, to the authors’ knowledge, these scoring systems have
not been critically assessed for reliability or validity, and have
some perceived shortcomings including lack of versatility,
comprehensive assessment of the joint, or standardization.
Therefore, we attempted to develop, optimize, and critically
assess a histologic evaluation system to address these short-
comings and provide a more optimal methodology for study of
OA in dogs.
To address perceived shortcomings, this assessment system
was developed to provide a more global assessment of the joint.
We addressed global joint assessment by including assessment
of synovium, subchondral bone, and meniscus; by including
gross scoring of tissues; and recommending multi-location
assessments of each tissue. As such, we provided two recom-
mended protocols for tissue processing because of the recog-
nized variation among investigators with respect to additional
outcome measures and requirements for aseptic processing. In
addition, we provided versatility and the potential for relative
“weighting” of various types of pathology by separating
J.L. Cook et al. / Osteoarthritis and Cartilage 18 (2010) S66eS79 S75categories of pathologic change into separate grading tables.
This allows investigators to assess the joints with relevance to
the hypothesis being tested, while still allowing for combined
scores for total or global joint assessment for comparison
among time points, studies, and centers. In order to allow for
these comparisons to be most accurate and informative, we
recommend a standardized methodology for grading tissues
which we feel helps to address issues regarding the problem of
evaluating the worst area vs the best area vs the average area.
Lastly, we critically assessed the reliability of this system for its
ability to consistently measure tissue pathology accurately
among multiple observers.
The proposed system for assessment of canine tissues appears to
provide an effective method for global assessment of articular
pathology in OA. The system is versatile, comprehensive, and reli-
able and appears to have advantages over other scoring systems for
progress in OA research.Disclosures
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